Neopterin ELISA
Ideal applications
- Early indication of complication in allograft recipients
- Screening of blood donor samples
- Prognostic marker for cardiovascular diseases
- Follow-up of traumatized patients in intensive care units
- Differential diagnosis of acute viral and bacterial infections
- Indicator of disease activity and therapy control in autoimmune diseases
- Complete kit
- Based on a competitive ELISA
- Pre-coated ELISA plates
- Assay completed within 2 hours
- Excellent reproducibility, linearity and recovery
- Only 10 µl of sample is needed
- Analyses neopterin levels in serum, plasma or urine samples
Background information
Neopterin is synthesized by macrophages upon stimulation with the cytokine interferon-gamma and is indicative of a pro-inflammatory immune status. Measurement of neopterin concentrations in body fluids like plasma, serum and urine provides information about cellular immune activation in humans under the control of T helper cells type 1.Neopterin concentrations correlate with the extent and activity of the disease, and are also useful to monitor during therapy in these patients. Elevated neopterin concentrations are among the best predictors of adverse outcome in patients with HIV infection, in cardiovascular disease and in various types of cancer.
Product details | ||||
| Item | Description | Test size | Product code | |
| Neopterin ELISA[IVD] CE | Neopterin ELISA assay quantification of neopterin in serum, plasma and urine | 96 tests | IQP-386 | |
Foreign language:
Neopterin ELISA (ES - FR - GE - IT - PT)
Related products
| Product name | Product code |
|---|---|
| MSDS Neopterin ELISA |
Copyright © 2010 IQ Products